Human hepatic iron overload syndromes;Les surcharges hépatiques en fer chez l'homme

Bulletin de l'Academie Nationale de Medecine

Volumn 189, Issue 8, 2005, Pages 1665-1677

  Deugnier, Yves ^a   Menkès, Charles Joël ^b   Godeau, Pierre ^b   Petithory, Jean Claude ^b   Battin, Jacques ^b   Nicolas, Jean Pierre ^b  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b NONE

Author keywords

Anemia, refractory; Hemochromatose; Liver cirrhosis; Thalassemia

Indexed keywords

EID: 33646257299     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)33423-5     Document Type: Review

References (38)

1. LORÉAL O., HAZIZA-PIGEON C., TROADEC M.B., DETIVAUD L., TURLIN B., COURSELAUD B. et al. - Hepcidin in iron metabolism. Curr. Protein Pept. Sci., 2005, 6, 279-91.
2. PAPANIKOLAOU G., SAMUELS M.E., LUDWIG E.H., MACDONALD M.L., FRANCHINI P.L., DUBE M.P. et al. - Mutations in hfe2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat. Genet., 2004, 36, 77-82.
3. ROETTO A., PAPANIKOLAOU G., POLITOU M., ALBERTI F., GIRELLI D., CHRISTAKIS J. et al. - Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat. Genet., 2003, 33, 21-2.
4. DEUGNIER Y., JOUANOLLE A.M., CHAPERON J., MOIRAND R., PITHOIS C., MEYER J.F. et al. - Gender-specific phenotypic expression and screening strategies in c282y-linked haemochromatosis : A study of 9396 french people. Br. J. Haematol., 2002, 118, 1170-8.
5. DEUGNIER Y., BRISSOT P. - Hémochromatoses génétiques et autres surcharges en fer. In : Benhamou J.P., McIntyre N., Rodes J., editors. Oxford textbook of clinical hepatology, Oxford, 2002.
6. GANDON Y., OLIVIE D., GUYADER D., AUBE C., OBERTI F., SEBILLE V. et al. - Non-invasive assessment of hepatic iron stores by mri. Lancet, 2004, 363, 357-62.
7. BEATON M., GUYADER D., DEUGNIER Y., MOIRAND R., CHAKRABARTI S., ADAMS P. - Noninvasive prediction of cirrhosis in c282y-linked hemochromatosis. Hepatology, 2002, 36, 673-8.
8. GUYADER D., JACQUELINET C., MOIRAND R., TURLIN B., MENDLER M.H., CHAPERON J. et al. - Noninvasive prediction of flbrosis in c282y homozygous hemochromatosis. Gastroenterology, 1998, 115, 929-36.
9. MOIRAND R., GUYADER D., MENDLER M.H., JOUANOLLE A.M., LE GALL J.Y., DAVID V. et al. - Hfe based re-evaluation of heterozygous hemochromatosis. Am. J. Med. Genet., 2002, 111, 356-61.
10. CAMASCHELLA C., ROETTO A., CALI A., DE GOBBI M., GAROZZO G., CARELLA M. et al. - The gene tfr2 is mutated in a new type of haemochromatosis mapping to 7q22. Nat. Genet., 2000, 25, 14-5.
11. PIETRANGELO A. - Non-HFE hemochromatosis. Hepatology, 2004, 39, 21-9.
12. NEMETH E., TUTTLE M.S., POWELSON J., VAUGHN M.B., DONOVAN A., WARD D.M. et al. - Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 2004, 306, 2090-3.
13. DE DOMENICO I., WARD D.M., NEMETH E., VAUGHN M.B., MUSCI G., GANZ T. et al. - The molecular basis of ferroportin-linked hemochromatosis. Proc. Natl. Acad. Sci. USA, 2005, 102, 8955-60.
14. HATANAKA Y., OKANO T., ODA K., YAMAMOTO K., YOSHIDA K. - Aceruloplasminemia with juvenile-onset diabetes mellitus caused by exon skipping in the ceruloplasmin gene. Intern. Med., 2003, 42, 599-604.
15. MENDLER M., TURLIN B., MOIRAND R., JOUANOLLE A., SAPEY T., GUYADER D. et al. - Insulin resistance - associated hepatic iron overload. Gastroenterology, 1999, 117, 1155-1163.
16. MOIRAND R., MORTAJI A., LORÉAL O., PAILLARD F., BRISSOT P., DEUGNIER Y. Liver iron overload with normal transferrin saturation : A new syndrome. Lancet, 1997, 349, 95-97.
17. TURLIN B., MENDLER M.H., MOIRAND R., GUYADER D., GUILLYGOMARCH A., DEUGNIER Y. - Histologic features of the liver in insulin resistance-associated iron overload. A study of 139 patients. Am. J. Clin. Pathol., 2001, 116, 263-70.
18. FERNANDEZ-REAL J., RICART-ENGEL W., ARROYO E., BALANÇA R., CASAMITJANA-ABELLA R., CABRERO D. et al. - Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care, 1998, 21, 62-68.
19. DANDONA P., ALJADA A., BANDYOPADHYAY A. - Inflammation : The link between insulin resistance, obesity and diabetes. Trends Immunol 2004 ; 25 : 4-7
20. BOWERING J., MASCH G.A., LEWIS A.R. - Enhancement of iron absorption in iron depleted rats by increasing dietary fat. J. Nutr., 1977, 107, 1687-93.
21. TANNER L., LIENHARD G. - Insulin elicits a redistribution of transferrin receptors in 3t3-11 adipocytes through an increase in the rate constant for receptor externalization. J. Biol. Chem., 1987, 262, 8975-8980.
22. VARGAS L., KAWADA M., BAZAES S., KARPLUS P., FAERMAN C. - Insulin antagonism : A novel role for human serum transferrin. Horm. Metab. Res., 1997, 30, 113-118.
23. POTASHNIK R., KOZLOVSKY N., BEN-EZRA S., RUDICH A., BASHAN N. - Regulation of glucose transport and glut-1 expression by iron chelators in muscle cells in culture. Am. J. Physiol. (Endocrinol. Metab.) 1995, 269, 1052-1058.
24. ANDREWS N.C. - Anemia of inflammation : The cytokine-hepcidin link. J. Clin. Invest. 2004, 113, 1251-3.
25. FACCHINI F.S., HUA N.W., STOOHS R.A. - Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. Gastroenterology, 2002, 122, 931-9.
26. GEORGE D.K., GOLDWURM S., MACDONALD G.A., COWLEY L.L., WALKER N.I., WARD P.J. et al. - Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology, 1998, 114, 311-8.
27. DEUGNIER Y. - Iron and liver cancer. Alcohol, 2003, 30, 145-50.
28. SALONEN J., NYYSSÖNEN K., KORPELA H., TUOMILEHTO J., SEPPÄNEN R., SALONEN R. - High stored iron levels are associated with excess risk of myocardal infarction in eastern finnish men. Circulation, 1992, 86, 803-811.
29. ROBLIN X., PHELIP J.M., HILLERET M.N., HELUWAERT F., BONAZ B., ZARSKI J.P. - La correction de l'insulino-résistance n'entraine pas la normalisation de rhyperferritinémie. Gastroenterol. Clin. Biol., 2003, 27, 1079-83.
30. GUILLYGOMARC'H A., MENDLER M.H., MOIRAND R., LAINE F., QUENTIN V., DAVID V. et al. - Venesection therapy of insulin resistance-associated hepatic iron overload. J. Hepatol., 2001, 35, 344-9.
31. DEUGNIER Y., TURLIN B., LE QUILLEUC D., MOIRAND R., LORÉAL O., MESSNER M. et al. - A reappraisal of hepatic siderosis in patients with end-stage cirrhosis : Practical implications for the diagnosis of hemochromatosis. Am. J. Surg. Pathol., 1997, 21, 669-75.
32. DETIVAUD L., NEMETH E., BOUDJEMA K., TURLIN B., TROADEC M.B., LEROYER P. et al. - Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood, 2005, 106, 746-8.
33. BRISSOT P., LORÉAL O. - Role of non-transferrin-bound iron in the pathogenesis of iron overload and toxicity. Adv. Exp. Med. Biol., 2002, 509, 45-53.
34. GANNE-CARRIE N., CHRISTIDIS C., CHASTANG C., ZIOL M., CHAPEL F., IMBERT-BISMUT F. et al. - Liver iron is predictive of death in alcoholic cirrhosis : A multivariate study of 229 consecutive patients with alcoholic and/or hepatitis c virus cirrhosis : A prospective follow up study. Gut., 2000, 46, 277-82.
35. TURLIN B., JUGUET F., MOIRAND R., LE QUILLEUC D., LORÉAL O., CAMPION J.P. et al. - Increased liver iron stores in patients with hepatocellular carcinoma developed on a noncirrhotic liver. Hepatology, 1995, 22, 446-50.
36. STUART K.A., FLETCHER L.M., CLOUSTON A.D., LYNCH S.V., PURDIE D.M., KERLIN P. et al. - Increased hepatic iron and cirrhosis : No evidence for an adverse effect on patient outcome following liver transplantation. Hepatology, 2000, 32, 1200-7.
37. KOWDLEY K.V., BRANDHAGEN D.J., GISH R.G., BASS N.M., WEINSTEIN J., SCHILSKY M.L. et al. - Survival after liver transplantation in patients with hepatic iron overload : The national hemochromatosis transplant registry. Gastroenterology, 2005, 129, 494-503.
38. GALANELLO R., PIGA A., ALBERTI D., ROUAN M.C., BIGLER H., SECHAUD R. - Safety, tolerability, and pharmacokinetics of ic1670, a new orally active iron-chelating agent in patients with transfusion-dependent iron overload due to beta-thalassemia. J. Clin. Pharmacol., 2003, 43, 565-72.